June 3, 2009 - The Chalk River Laboratories (CRL) nuclear reactor, which supplies about a third of the world’s medical isotopes, has been shut down since May 14 and is not expected to be back for at least three months, according to Atomic Energy of Canada Ltd. (AECL).

The reactor produces medical isotopes such as molybdenum-99 (Mo-99), which are used in diagnostic nuclear imaging scans.

AECL reported the NRU reactor at Chalk River would remain out of service for more than a month in order to investigate and repair a heavy water leak in the reactor vessel. The location of the heavy water leak has been identified at the base of the reactor vessel in a location where there is corrosion on the outside wall of the vessel.

“Sophisticated diagnostic procedures are required to determine the exact nature and extent of the repairs before returning the NRU reactor safely to service,” said Bill Pilkington, AECL’s senior vice-president and chief nuclear officer. “Based on our preliminary findings to date, we now believe that the NRU reactor will be out of service for at least three months.”

On June 2 AECL said it began the process of removing fuel rods from the NRU reactor as part of the process to repair the reactor and return it to service. There were about 100 rods in the reactor at the time NRU was shut down and officials said it will take an estimated three to four weeks to complete.

For more information: www.aecl.ca


Related Content

News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | Interventional Radiology

February 6, 2024 — RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology ...

Time February 06, 2024
arrow
News | Radiology Business

January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals ...

Time January 23, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

January 18, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved expanded MRI labeling ...

Time January 18, 2024
arrow
News | Radiology Business

December 14, 2023 — Nucleus RadioPharma, a fully integrated development, manufacturing, and supply chain organization ...

Time December 14, 2023
arrow
News | Radiation Oncology

October 17, 2023 — Radionetics Oncology, Inc., a clinical stage radiopharmaceutical company focused on the discovery and ...

Time October 17, 2023
arrow
News | Radiopharmaceuticals and Tracers

October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 05, 2023
arrow
Subscribe Now